These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 38254826)

  • 1. Hematological Neoplasms with Eosinophilia.
    Morales-Camacho RM; Caballero-Velázquez T; Borrero JJ; Bernal R; Prats-Martín C
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.
    Kelemen K; Saft L; Craig FE; Orazi A; Nakashima M; Wertheim GB; George TI; Horny HP; King RL; Quintanilla-Martinez L; Wang SA; Rimsza LM; Reichard KK
    Am J Clin Pathol; 2021 Feb; 155(2):179-210. PubMed ID: 33367563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.
    Tefferi A; Gotlib J; Pardanani A
    Mayo Clin Proc; 2010 Feb; 85(2):158-64. PubMed ID: 20053713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2019 Oct; 94(10):1149-1167. PubMed ID: 31423623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.
    Valent P
    Blood Rev; 2009 Jul; 23(4):157-65. PubMed ID: 19246139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the blood eosinophil count with hematological malignancies and mortality.
    Andersen CL; Siersma VD; Hasselbalch HC; Vestergaard H; Mesa R; Felding P; Olivarius ND; Bjerrum OW
    Am J Hematol; 2015 Mar; 90(3):225-9. PubMed ID: 25488524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenge of diagnosing and classifying eosinophilia and eosinophil disorders: A review.
    Szymczyk A; Jaworski J; Podhorecka M
    Cent Eur J Immunol; 2024; 49(1):60-69. PubMed ID: 38812609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma.
    Akiely R; Almasri F; Almasri N; Abu-Ghosh A
    Front Pediatr; 2022; 10():1059527. PubMed ID: 36589160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
    Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
    Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current differential diagnosis of hypereosinophilic syndrome].
    Dinić-Uzurov V; Lalosević V; Milosević I; Urosević I; Lalosević D; Popović S
    Med Pregl; 2007; 60(11-12):581-6. PubMed ID: 18666600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2022 Jan; 97(1):129-148. PubMed ID: 34533850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2015 Nov; 90(11):1077-89. PubMed ID: 26486351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential diagnosis of hypereosinophilia].
    Henes JC; Wirths S; Hellmich B
    Z Rheumatol; 2019 May; 78(4):313-321. PubMed ID: 30635705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic Malignancies Identified in Patients with Hypereosinophilia and Hypereosinophilic Syndromes.
    Jin JJ; Butterfield JH; Weiler CR
    J Allergy Clin Immunol Pract; 2015; 3(6):920-5. PubMed ID: 26342744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2017 Nov; 92(11):1243-1259. PubMed ID: 29044676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hematological malignancies with eosinophilia].
    Okamura S; Ikematsu W
    Nihon Rinsho; 1993 Mar; 51(3):800-5. PubMed ID: 8492461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid neoplasms with eosinophilia.
    Reiter A; Gotlib J
    Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report.
    Isaza AP; Quintero SC; González LPQ; Córdoba FEA; Olivar AFA; Ocaña JCB
    J Med Case Rep; 2023 Jan; 17(1):39. PubMed ID: 36698221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.
    Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
    Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.